Results 21 to 30 of about 182,488 (255)

Resveratrol Ameliorates Vancomycin-Induced Testicular Dysfunction in Male Rats

Medicina, 2023
Background and Objectives: Numerous studies have indicated that antibiotics may adversely affect testicular and sperm function. As an alternative to penicillin, vancomycin is a glycopeptide antibiotic developed to treat resistant strains of ...
Fahad S. Alshehri
doaj   +1 more source

Direct replacement of antibodies with molecularly imprinted polymer (MIP) nanoparticles in ELISA - development of a novel assay for vancomycin [PDF]

, 2013
A simple and straightforward technique for coating microplate wells with molecularly imprinted polymer nanoparticles (nanoMIPs) to develop ELISA type assays is presented here for the first time.
Guerreiro, Antonio R., Piletska, Elena V., Moczko, Ewa, Chianella, Iva, Caygill, J. S., Piletsky, Sergey A., Perez De Vargas Sansalvador, Isabel M., Whitcombe, Michael J.   +7 more
core   +1 more source

Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role

Infection and Drug Resistance, 2021
Xiao Li,1,* Wen Xu,1,* Ran Li,2 Qie Guo,1 Xiangpeng Li,1 Jialin Sun,1 Shuhong Sun,1 Jing Li1 1Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, People’s Republic of China; 2Department of ...
Li X, Xu W, Li R, Guo Q, Li X, Sun J, Sun S, Li J   +7 more
doaj  

Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient

World Allergy Organization Journal, 2013
The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to ...
Shanti Mahabir, Ren Yik Lim, Fidelma Fitzpatrick, Colm Magee, Mary Keogan   +4 more
doaj   +1 more source

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections

Frontiers in Pharmacology, 2022
Objective: The decision of vancomycin dosage for central nervous system (CNS) infections is still a challenge because its bactericidal nature in cerebrospinal fluid (CSF) has not been confirmed by human studies.
Shu-Ping Liu, Jing Xiao, Ya-Li Liu, Yue-E Wu, Hui Qi, Zhuang-Zhuang Wang, A-Dong Shen, A-Dong Shen, Gang Liu, Wei Zhao, Wei Zhao   +10 more
doaj   +1 more source

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit

Frontiers in Pediatrics, 2022
ObjectiveTo explore the efficacy and safety of vancomycin as measured by pharmacokinetic/pharmacodynamic parameters in children with severe infection in the Pediatric Intensive Care Unit (PICU) and to determine the appropriate threshold for avoiding ...
Bo Zhou, Bo Zhou, Bo Zhou, Bo Zhou, Wenyi Xiong, Ke Bai, Ke Bai, Ke Bai, Ke Bai, Hongxing Dang, Hongxing Dang, Hongxing Dang, Hongxing Dang, Jing Li, Jing Li, Jing Li, Jing Li, Feng Xu, Feng Xu, Feng Xu, Feng Xu, Yue-qiang Fu, Yue-qiang Fu, Yue-qiang Fu, Yue-qiang Fu, Chengjun Liu, Chengjun Liu, Chengjun Liu, Chengjun Liu   +28 more
doaj   +1 more source

Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States [PDF]

, 2012
This research was supported in part with federal funds from the NIAID/NIH/DHHS, including the Harvard-wide Program on Antibiotic Resistance (NIH grant AI083214), NIH grant EY017381 (M.S.G.), contract HHSN27220090018C, and the NARSA program supported ...
Griggs, Allison, Van Tonder, Andries, Allison Griggs, Mongodin, Emmanuel F., Kip Bodi, Bruce Birren, Palmer, Kelli L., Brian J. Haas, Bodi, Kip, Paul Godfrey, Haas, Brian J., Kelli L. Palmer, Birren, Bruce, Emmanuel F. Mongodin, Michael S. Gilmore, Cerqueira, Gustavo, Holden, Matthew T. G., Feldgarden, Michael, Gustavo Cerqueira, Wortman, Jennifer, Lawley, Trevor, Kos, Veronica N., Matthew T. G. Holden, Trevor Lawley, Gilmore, Michael, Jennifer Wortman, Michael Feldgarden, Christopher A. Desjardins, Godfrey, Paul, Steven R. Gill, Desjardins, Christopher A., Andries Van Tonder, Veronica N. Kos, Gilmore, Michael S., Gill, Steven R., Holden, Matthew T. G.; id_orcid   +35 more
core   +1 more source

Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital

International Journal of Pediatrics, 2018
Background. Vancomycin and piperacillin-tazobactam (PTZ) are commonly used as empirical therapy for patients with health care associated infections. Vancomycin has been recognized as a nephrotoxic agent and in a few cases in the literature PTZ has been ...
Mohammed Al Nuhait, Laila C. Abu Esba, Khalid Al Harbi, Meshary Al Meshary, Rami T. Bustami   +4 more
doaj   +1 more source

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci

Brazilian Journal of Infectious Diseases, 2015
Background: Vancomycin-resistant enterococci colonization has been reported to increase the risk of developing infections, including bloodstream infections.
Ahu Kara, İlker Devrim, Nuri Bayram, Nagehan Katipoğlu, Ezgi Kıran, Yeliz Oruç, Nevbahar Demiray, Hurşit Apa, Gamze Gülfidan   +8 more
doaj   +1 more source

Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort

Journal of Infection and Public Health, 2022
Background: Therapeutic drug monitoring (TDM) has proven effectiveness in maintaining efficacy and reducing toxicities associated with vancomycin. A trough level of (15–20 mg/L) for MRSA serious infections is recommended.
Juhaina Salim Al-Maqbali, Zahra Al Shukri, Nawf Al Sabahi, Intisar AL-Riyami, Abdullah M. Al Alawi   +4 more
doaj   +1 more source